Skip to main content
Premium Trial:

Request an Annual Quote

Motorola Bails Out of Deal with Molecular Staging

NEW YORK, May 31 – Motorola has decided to abandon its previously announced plans to exclusively license Molecular Staging’s rolling circle amplification technology for use in its diagnostic nucleic acid bioarrays, a spokeswoman for Molecular Staging said Thursday.

“Motorola does not have an exclusive license to the technology,” a spokeswoman for Molecular Staging said.

The spokeswoman said she did not know what prompted Motorola to cancel the agreement.

A Motorola spokeswoman declined to comment.

In December, Motorola announced that it had reached an agreement to exclusively license Molecular Staging’s technology in exchange for licensing fees and an equity investment in the privately-held company. Motorola also received an option to increase its stake in the company in the future.

It was not immediately clear whether Motorola had also cancelled its plans to invest in Molecular Staging.

RCAT is an amplification method designed to allow users to detect the presence of target molecules on a variety of formats.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.